admin – Page 17

“Crop Scouting with Drones: Identifying Crop Variability”

Learn how to evaluate plant health and detect crop stress with drone data and DroneDeploy

No longer do you have to rely on costly, time-intensive methods of collecting aerial crop data such as satellite imagery or manned aircraft. Drones enable you to assess plant health and spot crop variability in minutes.

For many, it can be hard to determine where to start or how you should start collecting actionable insights with your drone. In this guide, we address some of the most common questions, like “what are plant health algorithms”, “what kind of camera should I buy”, and “what is the difference between NDVI, false-NDVI and VARI.”

Download our guide to learn:

How to assess plant health and spot crop variability with your drone data
The difference between NDVI, false-NDVI, and VARI
The types of cameras required to evaluate plant health
Best practices for using plant health algorithms to make smarter crop management decisions

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

By clicking here and submitting this form I agree to Daily Techinfo using the information I provide to contact me about Daily Techinfo and its affiliates' products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, as well as our privacy practices and your rights, please visit Daily Techinfo's Privacy Policy.

“THE STATE OF MANUFACTURERS’ NEW PRODUCT INTRODUCTION (NPI) PROCESSES”

2017 Survey Report of Manufacturers Using SAP® ERP Systems

Who should read this report?

If you work for a large manufacturer that uses SAP ERP and are involved in launching new products, we think you’ll find the results of our NPI survey interesting.

Whether you are responsible for a line of products or are in a supply chain, IT or master data role, this report is a great way to learn what your peers are doing and planning to do when it comes to their New Product Introduction (NPI) or product launch processes.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“How Software Helps Pharma/Biotech Maximize Value of External Resources”

Perhaps more than any other industry, pharmaceutical and biotech companies rely on external resources–such as investors, strategic alliances, partnerships, licensing deals, and outside service providers–to finance products, expand geographically, lower costs, and, ultimately, increase revenues.

This paper focuses on the specific ways in which software developed for regulated industries can help pharmaceutical and biotech companies (a) secure the funding they may need to finance new products, (b) substantially lower costs through the effective management of strategic outsourcing, and (c) maximize the benefits of mergers and acquisitions.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“Strengthening the Detection of and Early Response to Public Health Emergencies”

Learn lessons from the West Africa Ebola Epidemic.

Summary Points

The international response to the West African Ebola virus disease epidemic has exemplified the great potential of the global public health community. However, the protracted early response also revealed critical gaps, which likely resulted in exacerbation of the epidemic.
It is incumbent on international health partners to learn from missteps that occurred in the early stages of the epidemic and strengthen our public health capacity to better respond to future public health emergencies.
Strategies to consider include development of a more precise system to risk stratify geographic settings susceptible to disease outbreaks, reconsideration of the 2005 International Health Regulations Criteria to allow for earlier responses to localized epidemics before they reach epidemic proportions, increasing the flexibility of the World Health Organization director general to characterize epidemics with more granularity, development of guidelines for best practices to promote partnership with local stakeholders and identify locally acceptable response strategies, and, most importantly, making good on international commitments to establish a fund for public health emergency preparedness and response.
The recent success of the global action to stem the Ebola virus disease epidemic is laudable but should not encourage complacency in our efforts to improve the global public health infrastructure.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“Save on Pharmacy Spending”

Lower your health care costs.

Employers are facing the highest health care costs in three years, yet the businesses we serve have saved $30 million in medical and pharmacy costs over the past two years. We’ve taken these costs out of our system so we can pass savings on to our members and clients. Some of Tufts Health Plan’s keys to driving costs down are:

Flexible, employer-specific plan options
Outreach program for lower-cost drug options
Specialized teams for medication support
Integrated pharmacy benefits manager
Active management for specialty drugs

Learn more about Tufts Health Plan today!

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“How To Choose An Immunoassay Platform For Cell & Gene Therapy Bioanalysis”

The key factors to automating assay development to get results quicker

Given the recent approval of an adeno-associated viral (AAV) vector gene therapy for spinal muscular atrophy (SMA) and the healthy pipeline of new treatments in development, the gene therapy landscape is highly competitive and timelines are compressed to bring new therapies to market.

In addition, the focus on patient safety creates very specialized demands on bioanalytical methods utilized for vector and host cell protein quantitation, and for immunogenicity monitoring. Since immunoassays are traditionally time consuming and laborious, choosing the right immunoassay platform to meet the demands of data quality and assay speed significantly affects development timelines and deadlines for regulatory submissions.

What’s in This White Paper:

Monitoring potential safety risks with immunoassays
The need for speed in the race to treat a select few
Bioanalysis methods that deliver the data

These are key factors to consider when choosing an immunoassay platform for cell and gene therapy bioanalysis in preclinical, clinical, and bioprocessing stages of development.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“The QMS Buyer’s Guide for Pharmaceutical Manufacturers”

How to choose the right QMS

Learn more about recent pharmaceutical manufacturing industry trends and discover all the tools and insights you need to help find the right QMS for your organization.

The QMS buyer’s guide helps answer the following questions:

What are the regulatory requirements for a Pharmaceutical QMS?

How to choose a QMS software that is designed for your company’s needs and goals?

What are the business benefits of a cloud-based QMS?

How to ensure a quick, smooth and effective QMS implementation?

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“The Future of Compliant Commerce in HLS Is Here. Are You Prepared?”

See our new data on consumer behavior in the healthcare space.

Astound’s latest health and life sciences report provides invaluable insights on the current state and future of HLS online, compliant commerce, and why embracing digital patient engagement solutions is the key to driving loyalty, brand valuation, and revenue.

The latest report from Astound Insights, Transforming the Global Healthcare Consumer Journey: Now and Beyond Covid-19, which surveyed 1,000 global healthcare consumers, revealed:

Virtual visits increased by 94% since the onset of the pandemic.
32% utilized a telehealth appointment to speak to their healthcare provider.
Use of appointment scheduling via online portals increased by 20%.
Globally, more than 60% of patients surveyed feel they do not have adequate access to healthcare.

Get the HLS data you need. Read our report today.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“Successful Strategies for Biomarker-Driven Research and Clinical Development”

Gain insights into every step of biomarker-driven research and clinical development from selecting biospecimens to evaluating complex genome signatures to overcoming trial hurdles.

Identify opportunities and mitigate challenges associated with biomarker-driven development with this new eBook. Whether you’re in the discovery stage, directing clinical trials or developing a CDx, you’ll receive critical insights into every step of the process. You’ll have the experience collected from working with cutting-edge innovators on successful treatments.

This free eBook, featuring insights published in Fierce Biotech, provides strategies on:

Developing the right biospecimen strategy to support biomarker discovery
Transitioning biomarkers from the preclinical to clinical setting
Evaluating complex genomic signatures and single-gene biomarkers across all phases of development
Overcoming common hurdles in biomarker-driven trials

Download now to access this important information.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission

“Quantum Computing for the Pharmaceutical Industry”

Quantum computers could hold the key to finding new ways of assembling molecules to create novel medications.

Pharmaceutical companies are researching whether quantum computers could enhance and accelerate the drug discovery process by finding new ways of assembling molecules to create new medications.

Download Now

Name *

First

Last

Company Name *

Job Title *

Email *

Select company Size... *

Phone No

Country *

I agree and give my permission